Analysis on clinical application of blood component transfusion in obstetric perinatal period
HE Feiyan1 XU Li2▲ XU Hengshi3
1.Department of Obstetrics and Gynecology, Shanghai Ninth People′s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 201999, China; 2.Medical Department, Shanghai Ninth People′s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 201999, China;
3.Department of Blood Transfusion, Shanghai Ninth People′s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 201999, China
Abstract：Objective To guide timely and rational use of blood in clinic through the analysis of the application of the blood in the obstetric perinatal period. Methods The clinical data of 31 patients who delivered and received perinatal transfusion in Shanghai Ninth People′s Hospital, Shanghai JiaoTong University School of Medicine from October 2013 to February 2017 was analyzed, and the utilization of blood components was retrospectively analyzed. Results The main infusion of blood components was red blood cell products, and the blood transfusion was mainly caused by uterine atony. Conclusion The blood component transfusion can contribute to effective utilization of the blood, improve the coagulation function and stop the bleeding, which is the key measure for maternal treatment. Besides, paying attention to prenatal examination and standardized diagnosis and treatment, and grasping the opportunity of blood transfusion and reasonable utilization of blood may contribute to cutting down the rate of blood transfusion, reducing the amount of blood transfusion, and reducing the maternal mortality.
[1] 李笑天.预防产后出血，降低孕产妇死亡率[J].中华围产医学杂志，2015，18（7）：491-493.
[2] 中华医学会妇产科学分会产科学组.产后出血预防与处理指南（2014）[J].中华妇产科杂志，2014，49（9）：641-646.
[3] Loudon I. Maternal mortality in the past and its relevance to developing countries today [J]. Am J Clin Nutr，2000， 72（1 Suppl）：241s-246s.
[4] 韦毅.子宫收缩乏力所致产后出血临床治疗进展[J].中外女性健康研究，2015（4）：18-19.
[5] Ducloy-Bouthors AS，Susen S，Wong CA，et al. Medical advances in the treatment of postpartum hemorrhage [J]. Anesth Analg，2014，119（5）：1140-1147.
[6] 张彩丽.成分输血在产后出血患者中的应用效果观察[J].实用妇科内分泌电子杂志，2015，2（3）：106-107.
[7] 周慧盈，赵佳丽，白帆.产后出血不规范用血致迟发性溶血输血反应1例[J].中国输血杂志，2016，29（5）：527-529.
[8] Stansbury LG，Dutton RP，Stein DM，et al. Controversy in trauma resuscitation：do ratios of plasma to red blood cells matter? [J]. Transfus Med Rev，2009，23（4）：255-265.
[9] Pasquier P，Gayat E，Rackelboom T，et al. An observational study of the fresh frozen plasma：red blood cell ratio in postpartum hemorrhage [J]. Anesth Analg，2013，116（1）：155-161.
[10] 许靖，高利臣，饶丽娟，等.新鲜冰冻血浆、冷沉淀和血小板在抢救并发凝血功能障碍产后出血中的作用分析[J].中国输血杂志，2016，29（6）：626-629.
[11] 刘兴会，张力，张静.《产后出血预防与处理指南（草案）》（2009）及《产后出血预防与处理指南（2014年版）》解读[J].中华妇幼临床医学杂志（电子版），2015，11（4）：433-447.
[12] Pacheco LD，Saade GR，Costantine MM，et al. An update on the use of massive transfusion protocols in obstetrics[J]. Am J Obstet Gynecol，2016，214（3）：340-344.
[13] Charbit B，Mandelbrot L，Samain E，et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage[J]. J Thromb Haemost，2007，5（2）：266-273.
[14] 邓钦尹，漆洪波.英国皇家妇产科医师学会《产科输血2015版》要点解读[J].中国实用妇科与产科杂志，2016， 32（9）：868-872.
[15] 吴思梦，王哲，胡清，等.围产期输血相关因素分析[J].中国输血杂志，2011，24（2）：131-132.
[16] Cheng WW，Lin SQ. Analysis of risk factors for uteroplacental apoplexy complicating placental abruption [J]. Zhonghua Fu Chan Ke Za Zhi，2008，43（8）：593-596.
[17] 钟逸锋，杨剑秋，王涛，等.产科围产期输血的原因[J].协和医学杂志，2015，6（4）：296-299.
[18] 罗培欣，黄欢佳，汤杰英，等.658例产后出血病例分析[J].实用妇产科杂志，2016，32（7）：541-544.
[19] 李红松.产后出血原因及相关危险因素影响的临床研究[J].河北医学，2016，22（7）：1168-1170.
[20] 余卓丽，梁惠兰，马春会，等.英国孕产妇出血管理系列指南主要推荐及其启示（五）——产后出血预防和管理指南[J].中国输血杂志，2017，30（3）：320-324.
[21] 花静，朱丽萍，杜莉，等.妊娠风险预警评估对改善围产结局的效果[J].中华围产医学杂志，2016，19（3）：200-205.
2017, Vol. 14 
京公网安备 11010502046598号